153 related articles for article (PubMed ID: 36759240)
21. Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.
Campian JL; Sarai G; Ye X; Marur S; Grossman SA
Head Neck; 2014 Dec; 36(12):1747-53. PubMed ID: 24174270
[TBL] [Abstract][Full Text] [Related]
22. Radiation-induced lymphopenia does not impact treatment efficacy in a mouse tumor model.
Telarovic I; Yong CSM; Guckenberger M; Unkelbach J; Pruschy M
Neoplasia; 2022 Sep; 31():100812. PubMed ID: 35667149
[TBL] [Abstract][Full Text] [Related]
23. A Systematic Review of Radiation-Related Lymphopenia in Genito-urinary Malignancies.
Elumalai T; Periasamy K; Rajendran I; Yedala A; Giridhar P; Upadhya R; Kim BK; Sharma A; Elghazawy H; Dhanireddy B; Mallick S; Hsieh CE; Johnny C; Venkatesulu B
Cancer Invest; 2021 Oct; 39(9):769-776. PubMed ID: 34313522
[TBL] [Abstract][Full Text] [Related]
24. Treatment failure prediction for head-and-neck cancer radiation therapy.
Rocha H; Khouri L; Lopes MC; Dias J; Ferreira B
Cancer Radiother; 2016 Jun; 20(4):268-74. PubMed ID: 27321413
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Spleen as an Organ at Risk in Radiation Therapy and Its Relationship With Radiation-Induced Lymphopenia: A Retrospective Study and Literature Review.
Alexandru M; Rodica A; Dragos-Eugen G; Mihai-Teodor G
Adv Radiat Oncol; 2021; 6(6):100761. PubMed ID: 34934857
[TBL] [Abstract][Full Text] [Related]
26. [Re-irradiation of head and neck cancers: Target volumes, technical evolutions and prospects].
Kinj R; Bénézery K; Florescu C; Gery B; Habrand JL; Thariat J
Cancer Radiother; 2018 Apr; 22(2):171-179. PubMed ID: 29428789
[TBL] [Abstract][Full Text] [Related]
27. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
28. Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.
Cho Y; Park S; Byun HK; Lee CG; Cho J; Hong MH; Kim HR; Cho BC; Kim S; Park J; Yoon HI
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1065-1073. PubMed ID: 31476418
[TBL] [Abstract][Full Text] [Related]
29. Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients.
Brightwell R; Eng K; Lele S
Eur J Gynaecol Oncol; 2017; 38(3):378-381. PubMed ID: 29693877
[TBL] [Abstract][Full Text] [Related]
30. Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents.
Pham TN; Coupey J; Toutain J; Candéias SM; Simonin G; Rousseau M; Touzani O; Thariat J; Valable S
Int J Radiat Biol; 2024; 100(5):744-755. PubMed ID: 38466699
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
[TBL] [Abstract][Full Text] [Related]
32. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
[TBL] [Abstract][Full Text] [Related]
33. [Reirradiation of head and neck cancers].
Doyen J; Lam Cham Kee D; Krebs L; Guigay J; Dassonville O; Peyrade F; Poissonnet G; Saâda-Bouzid E; Sudaka A; Bozec A; Bénézery K
Cancer Radiother; 2017 Oct; 21(6-7):521-526. PubMed ID: 28826697
[TBL] [Abstract][Full Text] [Related]
34. Role of Interleukin-7 in the Development of and Recovery from Radiation-Induced Lymphopenia: A Post-hoc Analysis of a Prospective Cohort.
Byun HK; Chung SY; Kim KJ; Seong J
Cancer Res Treat; 2021 Oct; 53(4):962-972. PubMed ID: 33540496
[TBL] [Abstract][Full Text] [Related]
35. Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature.
Danckaert W; Spaas M; Vandecasteele K; De Wagter C; Ost P
Radiother Oncol; 2022 May; 170():64-69. PubMed ID: 35257847
[TBL] [Abstract][Full Text] [Related]
36. Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancers.
Mouttet-Audouard R; Gras L; Comet B; Lartigau E
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):137-41. PubMed ID: 22249172
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy.
Venkatesulu B; Giridhar P; Pujari L; Chou B; Lee JH; Block AM; Upadhyay R; Welsh JS; Harkenrider MM; Krishnan S; Verma V; En Hsieh C; Pradhan S; Small W; Solanki AA
Radiother Oncol; 2022 Dec; 177():81-94. PubMed ID: 36334694
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy and radiotherapy - a future partnership Focus on radiation induced lymphopenia (RIL) implications.
Mirestean CC; Iancu RI; Iancu DT
Bratisl Lek Listy; 2023; 124(1):70-73. PubMed ID: 36519611
[TBL] [Abstract][Full Text] [Related]
39. Lymphopenia after palliative radiotherapy for vertebral metastases.
Takeda K; Umezawa R; Yamamoto T; Takahashi N; Suzuki Y; Kishida K; Omata S; Jingu K
J Radiat Res; 2024 May; ():. PubMed ID: 38818633
[TBL] [Abstract][Full Text] [Related]
40. Radiation therapy on primary tumour of synchronous metastatic head and neck squamous cell carcinomas.
Tang É; Nguyen TV; Clatot F; Rambeau A; Johnson A; Sun XS; Tao Y; Thariat J
Cancer Radiother; 2020 Oct; 24(6-7):559-566. PubMed ID: 32753240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
